On 2026-05-11, Eikon Therapeutics, Inc. (EIKN) announced earnings per share of $-2.46 for the fiscal quarter ending 2026-03-31, missing the average analyst estimate of $-1.47.

The next expected annoucement date for quarterly earnings is 2026-08-17, with an average estimated earnings per share of $-1.61 for the fiscal quarter ending 2026-06-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.